In this paper, the authors investigate the rise of industrial research laboratories in the U.S. pharmaceutical industry between 1927 and 1946. Evidence suggests that institutional factors, namely the presence of universities dedicated to research, played a significant role in the establishment and diffusion of private pharmaceutical research laboratories.
If the best universities in the world – who have the widest choice of candidates – systematically appoint top researchers as their vice chancellors and presidents, is this one form of evidence that, on average, better researchers make better leaders? This paper addresses the first part of the question: are they currently appointing distinguished researchers? The study documents a positive correlation between the lifetime citations of a university’s president and the position of that university in a world ranking.
This paper investigates both the determinants and the impact of overseas subsidiaries R&D activities, using firm-level panel data for Japanese multinational enterprises. The evidence suggests that overseas innovative R&D aims at the exploitation of foreign advanced knowledge, and by doing so, it helps to raise the productivity of the parent firm.
This paper investigates the hypothesis that social capital is a crucial factor in explaining technological innovation in
industrial districts or, more generally, in firms’ clusters.
The authors extend the R&D cooperation model to asymmetric firms, focusing on the incentives for cooperating with firms characterized by different levels of efficiency.
The paper develops a formal model of coalition-building (“network” formation) among research units that seek competitive funding from a supra-regional program, while also drawing support from their respective regional funding agencies.
The authors analyse strategic interaction in R&D internationalization decisions by two multinational firms competing both abroad and in their home markets and examine different incentives for foreign R&D faced by technology leaders and technology laggards.
This paper aims at assessing the impact of R&D spillovers on firms’ economic performance as measured by productivity growth.
The report indicates that the U.S. is currently the global leader in nanotechnology R&D, number of nanotechnology start-up companies, and research output as measured by patents and publications. However, that role is under increasing competitive pressure from other nations.
The economic letter discusses how the unique economic
nature of R&D may bear on the question of the constitutionality of state R&D tax credits.